Medical Ikkou Group Co., Ltd. (3353) AI Stock Analysis

1 Followers

Medical Ikkou Group Co., Ltd.

(TSE/TYO:3353)

Select Model

Rating:63Neutral

Price Target:JPY 2,936.00▲(7.74% Upside)

Action:downgraded

Date:11/05/26

The score is primarily supported by attractive valuation (low P/E and strong dividend yield) and generally stable fundamentals (improving revenue trend and reduced leverage). It is held back by a clear cash-flow weakness (poor and volatile cash conversion) and bearish technicals (negative MACD and price below major moving averages).

Positive Factors

Improving Revenue GrowthRevenue growth accelerated materially across the reported periods, indicating stronger top-line momentum than in 2023. Continued expansion can improve dispensing-pharmacy network utilization, support operating scale, and provide a durable base for earnings growth over the next several quarters.

Negative Factors

Weak Cash ConversionVery weak cash conversion in the latest year reduces confidence in the durability of reported profits. If operating cash flow continues to lag earnings, working-capital demands or investment needs could constrain internally funded growth and make financial performance more volatile.

Medical Ikkou Group Co., Ltd. (3353) vs. iShares MSCI Japan ETF (EWJ)

Market Cap: JPY 10.26B
Dividend Yield: 4.40%
Average Volume (3M): 2,070
Price to Earnings (P/E): 7.0
Beta (1Y): 0.29
Revenue Growth: 6.91%
EPS Growth: 33.61%
Country: Japan
Employees: 1,608
Sector: Industrials
Sector Strength: 63
Industry: Conglomerates

Medical Ikkou Group Co., Ltd. Business Overview & Revenue Model

Company Description

Medical Ikkou Group Co.,Ltd. is a Japanese enterprise primarily known for managing dispensing pharmacies across the nation. Beyond its extensive pharmacy operations, the company diversified its activities to include the management of various care fac...

How the Company Makes Money

Medical Ikkou Group Co., Ltd. makes money mainly by operating dispensing pharmacies that fill outpatient prescriptions issued by medical institutions. Revenue is generated when the company dispenses prescription medicines and bills the applicable pay...

Medical Ikkou Group Co., Ltd. Financial Statement Overview

Summary

Income statement and balance sheet are solid (scores 74 and 70) with improving revenue momentum and declining leverage, but the cash flow profile is a major drag (cash flow score 46) due to weak and volatile cash conversion versus earnings in the most recent year.

Income Statement

74Positive

Balance Sheet

70Positive

Cash Flow

46Neutral

Financial statement breakdown
Breakdown	TTM	Feb 2026	Feb 2025	Feb 2024	Feb 2023	Feb 2022
Income Statement
Total Revenue	54.98B	54.98B	48.39B	39.90B	33.90B	33.60B
Gross Profit	6.36B	6.36B	5.61B	4.38B	2.97B	3.37B
EBITDA	2.63B	2.63B	2.46B	2.34B	1.78B	2.15B
Net Income	1.28B	1.28B	1.13B	1.04B	759.60M	852.33M
Balance Sheet
Total Assets	37.52B	37.52B	34.23B	31.66B	27.51B	29.09B
Cash, Cash Equivalents and Short-Term Investments	6.12B	6.12B	6.77B	7.70B	6.44B	7.99B
Total Debt	10.36B	10.36B	10.04B	9.60B	9.15B	11.35B
Total Liabilities	21.24B	21.24B	19.52B	17.82B	14.90B	17.17B
Stockholders Equity	15.63B	15.63B	14.10B	13.24B	12.05B	11.38B
Cash Flow
Free Cash Flow	0	219.98M	201.34M	3.97B	995.40M	812.29M
Operating Cash Flow	0	1.21B	1.20B	4.28B	1.31B	1.14B
Investing Cash Flow	0	-1.81B	-1.13B	-3.22B	-477.52M	539.48M
Financing Cash Flow	0	-283.62M	-1.03B	277.76M	-2.37B	-690.26M

Medical Ikkou Group Co., Ltd. Technical Analysis

Technical Analysis SentimentNegative

Last Price2725.00

Price Trends

50DMA2784.92Negative

100DMA2770.06Negative

200DMA2788.89Negative

Market Momentum

MACD-21.50Positive

RSI41.49Neutral

STOCH55.31Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3353, the sentiment is Negative. The current price of 2725.00 is below the 20-day moving average (MA) of 2759.75, below the 50-day MA of 2784.92, and below the 200-day MA of 2788.89, indicating a bearish trend. The MACD of -21.50 indicates Positive momentum. The RSI at 41.49 is Neutral, neither overbought nor oversold. The STOCH value of 55.31 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:3353.

Medical Ikkou Group Co., Ltd. Peers Comparison

Overall Rating

UnderperformOutperform

Sector (63)

Financial Indicators

JP:3353 against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
JP:7509	72Outperform	JPY 6.41B	4.46	―	3.58%	0.18%	-2.47%
JP:7119	69Neutral	JPY 20.87B	18.00	―	2.10%	-1.37%	48.83%
JP:9248	67Neutral	JPY 14.02B	5.17	―	3.88%	8.74%	―
Sector *	63Neutral	$10.79B	15.43	7.44%	2.01%	2.89%	-14.66%
JP:3353	63Neutral	JPY 9.42B	7.04	―	4.40%	6.91%	33.61%
JP:2462	56Neutral	JPY 28.08B	12.82	―	4.08%	5.94%	-0.10%
JP:6838	54Neutral	JPY 9.29B	19.00	―	0.95%	―	―

* Industrials Sector Average

Performance Comparison

JP:3353 and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
JP:3353	Medical Ikkou Group Co., Ltd.	2725.00	112.57	4.31%
JP:2462	LIKE, Inc.	1470.00	25.05	1.73%
JP:6838	Tamagawa Holdings Co., Ltd.	1054.00	270.51	34.53%
JP:7119	halmek holdings Co.,Ltd.	1856.00	531.83	40.16%
JP:7509	I. A Group Corporation	4330.00	359.16	9.04%
JP:9248	People, Dreams & Technologies Group Co., Ltd.	1546.00	-36.36	-2.30%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 05, 2026

Medical Ikkou Group Co., Ltd. AI Stock Analysis